Canadian Cardiovascular Society Sets New Guidelines for Management of Lipid Metabolism Disorders That Affect Cholesterol and Cause Atherosclerosis
Elsevier BVThe Canadian Cardiovascular Society (CCS) has published an important update to its guidelines for the management of dyslipidemia - lipid metabolism disorders – that can cause cardiovascular disease. The guidelines update evidence-based guidance for cardiologists and other clinicians regarding which patients will benefit from statin therapy. There is also new information on the use of health behavior modifications and non-statin medications to help doctors make the difficult decisions about when to use drugs to treat cholesterol and when other approaches are possible.